Controlling Abl: Auto-inhibition and co-inhibition?

Nature Cell Biology

Volumn 6, Issue 1, 2004, Pages 3-7

  Wang, Jean Y J ^a  

^a SECTION OF MOLECULAR BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2,6 DICHLOROPHENYL) 2 [3 (HYDROXYMETHYL)ANILINO] 8 METHYLPYRIDO[2,3 D]PYRIMIDIN 7(8H) ONE; ABELSON KINASE; BCR ABL PROTEIN; CELL PROTEIN; F ACTIN; IMATINIB; MYRISTIC ACID; PROTEIN PAG; PROTEIN SERINE THREONINE KINASE; PROTEIN SH2; PROTEIN TYROSINE KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CHRONIC MYELOID LEUKEMIA; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; LEUKEMOGENESIS; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; FEEDBACK SYSTEM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; REVIEW;

ANIMALS; FEEDBACK, BIOCHEMICAL; MICE; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-ABL;

EID: 1342289531     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb0104-3     Document Type: Article

References (37)

1. Woodring, P. J., Hunter, T. & Wang, J. Y. Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J. Cell Sci. 116, 2613-2626 (2003).
2. Puri, P. L. et al. A myogenic differentiation checkpoint activated by genotoxic stress. Nature Genet. 32, 585-593 (2002).
3. Wang, J. Y. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19, 5643-5650 (2000).
4. Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-Abl tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031-1037 (2001).
5. Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-Abl gene mutation or amplification. Science 293, 876-880 (2001).
6. Nagar, B. et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859-871 (2003).
7. Kemp, B. E. & Pearson, R. B. Intrasteric regulation of protein kinases and phosphatases. Biochim Biophys Acta 1094, 67-76 (1991).
8. Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275-282 (2002)
9. Robinson, D. R., Wu, Y. M. & Lin, S. F. The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557 (2000).
10. Harrison, S. C. Variation on an Src-like theme. Cell 112, 737-740 (2003).
11. Barila, D. & Superti-Furga, G. An intramolecular SH3-domain interaction regulates c-Abl activity. Nature Genet. 18, 280-282 (1998).
12. Brasher, B. B. & Van Etten, R, A. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J. Biol. Chem. 275, 35631-35637 (2000).
13. Tanis, K. Q., Veach, D., Duewel, H. S., Bornmann, W. G. & Koleske, A. J. Two distinct phosphorylation pathways have additive effects on abl family kinase activation. Mol. Cell. Biol. 23, 3884-3896 (2003).
14. Nagar, B. et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 62, 4236-4243 (2002).
15. Azam, M., Latek, R. R. & Daley, G. Q. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-Abl. Cell 112, 831-843 (2003).
16. Hantschel, O. et al. A myristoyl/phosphatyrosine switch regulates c-Abl. Cell 112, 845-857 (2003).
17. Pluk, H., Corey, K. & Superti-Furga, G. Autoinhibition of c-Abl. Cell 108, 247-259 (2002).
18. Wang, J. Y. J. Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids. Oncogene Res, 3, 293-298 (1988).
19. Plattner, R, et al. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-γ1. Nature Cell Biol. 5, 309-319 (2003).
20. Wang, J. Y. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3, 35-43 (1993).
21. Wen, S. T. & Van Etten, R. A. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467 (1997).
22. Wood, Z. A., Schroder, E., Robin Harris, J. & Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40 (2003).
23. Welch, P. J. & Wang, J. Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75, 779-90 (1993).
24. Woodring, P. J., Hunter, T. & Wang, J. Y. Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J. Biol. Chem. 276, 27104-27110 (2001).
25. Darnell, G. A. et al. Inhibition of retinoblastoma protein degradation by interaction with the serpin PAI-2 via a novel consensus motif. Mol. Cell. Biol, 23, 6520-6532 (2003).
26. Woodring, P. J. et al. Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J. Cell Biol. 156, 879-892 (2002).
27. Smith, K. M., Yacobi, R. & Van Etten, R. A. Autoinhibition of Bcr-Abl through its SH3 domain. Mol. Cell 12, 27-37 (2003).
28. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A. & Pendergast, A. M. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400-2411 (1999).
29. Foray, N. et al. Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol. Cell Biol. 22, 4020-4032 (2002).
30. Yarden, R. I. & Brody, L. C. BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl Acad. Sci. USA 96, 4983-4988 (1999).
31. Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939 (2000).
32. Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
33. Cong, F. et al. Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. Mol. Cell 6, 1413-1423 (2000).
34. Echarri, A. & Pendergast, A. M. Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11, 1759-1765 (2001).
35. Kipreos, E. T. & Wang, J. Y. Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity, Science 248, 217-220 (1990).
36. Barila, D. et al. Caspase-dependent cleavage of c-Abl contributes to apoptosis. Mol. Cell. Biol. 23, 2790-2799 (2003).
37. Hirotsu, S. et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product. Proc. Natl Acad. Sci. USA 96, 12333-12338 (1999).